Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Checkmate Pharmaceuticals, Inc. (CMPI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18
   10-K10-KS-1/A
Revenues  0.00.018.2
            Revenue growth   -100.0% 
Cost of goods sold  0.00.036.3
Gross profit  0.00.0-18.2
            Gross margin    -100.0%
Selling, general and administrative   [+]10.24.62.8
Research and development  26.724.3 
EBIT   [+]-36.9-28.9-21.0
            EBIT margin    -115.5%
Interest income  0.10.2 
Other income (expense), net   [+]-0.10.40.2
Pre-tax income  -36.9-28.3-20.8
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -42.9-35.00.0
            Net margin    -0.1%
   
Basic EPS   [+]($4.49)($24.16)($18.14)
Diluted EPS   [+]($4.49)($24.16)($18.14)
   
Shares outstanding (basic)   [+]9.61.50.0
Shares outstanding (diluted)   [+]9.61.50.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy